0000904454-15-000414.txt : 20150619
0000904454-15-000414.hdr.sgml : 20150619
20150619182334
ACCESSION NUMBER: 0000904454-15-000414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150618
FILED AS OF DATE: 20150619
DATE AS OF CHANGE: 20150619
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GENOCEA BIOSCIENCES, INC.
CENTRAL INDEX KEY: 0001457612
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: 617-876-8191
MAIL ADDRESS:
STREET 1: 100 ACORN PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
FORMER COMPANY:
FORMER CONFORMED NAME: GENOCEA BIOSCIENCES INC
DATE OF NAME CHANGE: 20090304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polaris Venture Partners Special Founders' Fund V, L.P.
CENTRAL INDEX KEY: 0001439586
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 15943327
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polaris Venture Partners Founders' Fund V, L.P.
CENTRAL INDEX KEY: 0001439588
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 15943328
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polaris Venture Partners Entrepreneurs' Fund V, L.P.
CENTRAL INDEX KEY: 0001439587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 15943329
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polaris Venture Partners V, L.P.
CENTRAL INDEX KEY: 0001439590
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 15943330
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Polaris Venture Management Co. V, L.L.C.
CENTRAL INDEX KEY: 0001439589
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36289
FILM NUMBER: 15943331
BUSINESS ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-290-0770
MAIL ADDRESS:
STREET 1: 1000 WINTER STREET
STREET 2: SUITE 3350
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2015-06-18
0001457612
GENOCEA BIOSCIENCES, INC.
GNCA
0001439589
Polaris Venture Management Co. V, L.L.C.
C/O POLARIS VENTURE PARTNERS
1000 WINTER STREET SUITE 3350
WALTHAM
MA
02451
0
0
1
0
0001439590
Polaris Venture Partners V, L.P.
C/O POLARIS VENTURE PARTNERS
1000 WINTER STREET SUITE 3350
WALTHAM
MA
02451
0
0
1
0
0001439587
Polaris Venture Partners Entrepreneurs' Fund V, L.P.
C/O POLARIS VENTURE PARTNERS
1000 WINTER STREET SUITE 3350
WALTHAM
MA
02451
0
0
1
0
0001439588
Polaris Venture Partners Founders' Fund V, L.P.
C/O POLARIS VENTURE PARTNERS
1000 WINTER STREET SUITE 3350
WALTHAM
MA
02451
0
0
1
0
0001439586
Polaris Venture Partners Special Founders' Fund V, L.P.
C/O POLARIS VENTURE PARTNERS
1000 WINTER STREET SUITE 3350
WALTHAM
MA
02451
0
0
1
0
Common Stock
2015-06-18
4
S
0
29004
13.04
D
1969606
I
By the Polaris Funds
Common Stock
2015-06-19
4
S
0
1000
13.00
D
1968606
I
By the Polaris Funds
Consists of 27,987 shares sold by Polaris Venture Partners V, LP ("PVP-V"); 545 shares sold by Polaris Venture Partners Entrepreneurs' Fund V, L.P. ("PVP-E"); 192 shares sold by Polaris Venture Partners Founders' Fund V, L.P. ("PVP-F"); and 280 shares sold by Polaris Venture Partners Special Founders' Fund V, L.P. ("PVP-S"). PVP-V, PVP-E, PVP-F and PVP-S may be referred to herein collectively as the "Polaris Funds"
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.42. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Consists of 1,900,542 shares directly beneficially owned by PVP-V; 37,038 shares directly beneficially owned by PVP-E; 13,019 shares directly beneficially owned by PVP-F; and 19,007 shares directly beneficially owned by PVP-S.
Jonathan Flint and Terrance McGuire, managing members of Polaris Venture Management Co. V, L.L.C., exercise voting and investment power with respect to Polaris Venture Management Co. V, L.L.C. As members of the general partner and North Star Venture Management 2000, LLC, the Polaris Management Members may be deemed to share voting and investment powers for the shares held by the Polaris Funds. The Polaris Management Members disclaim beneficial ownership of all such shares held by the funds and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of their proportionate pecuniary interests therein. Kevin Bitterman, a director of the Issuer, has an assignee interest in Polaris Venture Management Co. V, L.L.C. To the extent that he is deemed to share voting and investment powers with respect to the shares held by the Polaris Funds, Dr. Bitterman disclaims (cont.)
Consists of 964 shares sold by PVP-V; 19 shares sold by PVP-E; 7 shares sold by PVP-F; and 10 shares sold by PVP-S.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.10. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Consists of 1,899,578 shares directly beneficially owned by PVP-V; 37,019 shares directly beneficially owned by PVP-E; 13,012 shares directly beneficially owned by PVP-F; and 18,997 shares directly beneficially owned by PVP-S.
(footnote (4) continued) beneficial ownership of all the shares held by the funds and this report shall not be deemed an admission of beneficial ownership of such shares for the purposes of Section 16 or for any other purpose, except to the extent of his proportionate pecuniary interest therein.
/s/ John Gannon, for Polaris Venture Management Co. V, L.L.C.
2015-06-19
/s/ John Gannon, for Polaris Venture Partners V, L.P.
2015-06-19
/s/ John Gannon, for Polaris Venture Partners Entrepreneurs Fund V, L.P.
2015-06-19
/s/ John Gannon, for Polaris Venture Partners Founders' Fund V, L.P.
2015-06-19
/s/ John Gannon, for Polaris Venture Partners Special Founders' Fund V, L.P.
2015-06-19